Pfizer Submits Data To FDA For Childern Emergency Use Of COVID-19 Vaccine
Written by DJ Sight on October 1, 2021
Pfizer submitted data to the FDA To get the COVID-19 vaccine ready for kids between the ages of 5 and 11.
The FDA will go over the data for the next couple weeks to make sure it’s safe for younger children to take the vaccine before passing it thourgh.
Pfizer did a vaccine trial that included 2000 children once the FDA finish analyzing the could push emergency use of the COVID-19 vaccine for children ages 5-11.
https://www.nbcnews.com/news/us-news/pfizer-seeks-fda-authorization-covid-vaccine-children-ages-5-11-n1279939
Continue reading
